Medical Products Stock Expands To Artificial Intelligence In Cancer Research

Medical Products Stock News

Medical Products Stock News

Artificial Intelligence Used In Cancer Research

The January 30th show features Medical Waste disposal products stock

Skyline Medical, Inc. (stock symbol: SKLN

that has expanded (through the recent purchase of Helomics, Inc.)  into two emerging areas of the healthcare industry: precision medicine and big data. This will enable the company to help advance the use of artificial intelligence in cancer research.

Dr. Carl Schwartz presents vital new updates at Skyline Medical, Inc.

This includes the new company name, major sales growth and projected 2018 sales.

In addition Skyline Medical has completed the purchase of preferred stock in Helomics Corporation.

Medical Waste Management Stock News

See corporate site:

Get SKLN stock quote

See Investors Information Resources Page


See Latest Company News

Listen to a replay of the show:


The show includes an interview with Gerry Vardzel, President and CEO of Helomics. a Personalized Cancer Healthcare & Integrated Contract Services company.

See corporate website:

Helomics® is a precision diagnostic company and integrated clinical contract research organization whose mission is to improve patient care by partnering with pharmaceutical, diagnostic, and academic organizations to bring innovative clinical products and technologies to the marketplace.

Helomics has established operations that bridge two emerging areas of the healthcare industry: precision medicine and big data. Helomics’ competitive advantage lies in its proprietary D-CHIP™ database, which contains de-identified data compiled from more than a decade of clinical testing of tumor responses to drugs coupled to an Artificial Intelligence (AI) -powered bioinformatics engine which generates actionable scientific insights from this rich data. These insights are used by BioPharma companies in the research and development of targeted cancer treatments for any given patient profile.


Mr. Vardzel has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions.  Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh

Medical Products Company News 


Skyline Medical Projects 100 STREAMWAY System Sales in the U.S. in 2018 – See News


Skyline Medical Completes Purchase of Preferred Stock in Helomics Corporation – See News


Skyline Medical Announces Corporate Name Change to Precision Therapeutics – See News


Skyline Medical Opens New European Headquarters to Drive International Sales of the STREAMWAY System – See News


More on  Skyline Medical Inc. medical waste disposal systems products. 


Skyline Medical Inc.’s STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids, which results in:

  • Reducing overhead costs to hospitals and surgical centers
  • Improving their Occupational Safety and Health Administration (OSHA) and other regulatory compliance
  • Enhancing the efficiency of the operating room and thereby making surgeries more profitable

Skyline Medical Inc.’s STREAMWAY System is eco-friendly as it addresses the numerous bloody, potentially disease infected canisters that go into U.S. landfills every year. These tainted canisters—which are generally made of plastic—can take centuries to biodegrade, but with installations of the STREAMWAY System, the number of these canisters can be significantly reduced.

Medical stocks to buy


The new standard in waste fluid management.




Medical waste management stocks

The STREAMWAY System installs in or on the wall with direct-to-drain fluid removal medical product for safe, continuous collection and disposal. The illuminated touch screen provides safe control over surgical suction levels and displays automated measurement of volumes, while the single patient procedure filter and tissue trap both prevents cross contamination and allows for tissue retrieval. To clean, simply detach the filter, connect the cleaning solution bottle and activate the rapid clean cycle using the touch screen.


investment news show

Investment News Show

Money Info Show Airs

10 AM to 11 AM EDT

Every Tuesday

Investment News Show


Use this Link To Watch The Show:

Money Info

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

The show is broadcast live on the internet and on the air  from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast 

Money Info is hosted by investing experts Mike King and Charles Moskowitz together with radio broadcasting professional Greg Wyatt.

Undervalued Medical Stocks 

Medical Products Company Stock News

Artificial Intelligence Used In Cancer Research